Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-031149
Filing Date
2021-08-02
Accepted
2021-08-02 21:27:12
Documents
1
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15922
  Complete submission text file 0000899243-21-031149.txt   18391
Mailing Address C/O PROTINE DESIGN LAB 7442 NORTH MARCER WAY MERCER ISLAND WA 98040
Business Address
MCDADE MARK (Reporting) CIK: 0001242126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211137627

Mailing Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004
Business Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004 (425) 709-0772
Qiming U.S. Healthcare Fund II, L.P. (Reporting) CIK: 0001765710 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211137629

Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004
Business Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004 425-709-0772
Qiming U.S. Healthcare GP II, LLC (Reporting) CIK: 0001868862 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 211137628